Impulse Dynamics: Clinical Trials

17 trials sponsored by Impulse Dynamics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting, 5 completed, 3 terminated, 2 active not recruiting. 9 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 4, Recruiting 2, Terminated 2, Active not recruiting 1

Follow Impulse Dynamics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Cardiac Contractility Modulation (CCM) - Heart Failure and Reduced Ejection Fraction, NYHA Class III Heart Failure
RecruitingImpulse Dynamics42002025-11-182026-03-24
CCM OPEN HF Registry
Heart Failure
RecruitingImpulse Dynamics55002025-11-012026-10-27
The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF
Cardiac Contractility Modulation (CCM) implant - Symptomatic Congestive Heart Failure
RecruitingQuovadis Associazione1202025-07-102025-07-29
CCM and Implementation of Guideline-Directed Medical Therapy in Patients With Heart Failure (Fix-GDMT-HF)
Heart Failure
RecruitingImpulse Dynamics2002025-02-012025-07-11
Assessment of Combined CCM and ICD Device in HFrEF
OPTIMIZER® Integra CCM-D System (Treatment Arm) - Heart Failure, Heart Failure With Reduced Ejection Fraction
Not applicableActive not recruitingImpulse Dynamics3002023-05-172026-05-27
Arrythmia Burden in Cardiac Contractility Modulation (CCM)
Impulse Dynamics Optimizer Device - Atrial Fibrillation, Arrythmia
TerminatedHackensack Meridian Health22023-05-012024-08-19
Cardiac Contractility Modulation in Chagas Heart Disease
Cardiac Contractility Modulation (CCM), CRT - Chagas Cardiomyopathy, Heart Failure
Not applicableRecruitingInCor Heart Institute602022-05-252026-07-08
Assessment of CCM in HF With Higher Ejection Fraction
Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System, OPTIMIZER™ Smart Mini System - Heart Failure, Heart Failure With Preserved Ejection Fraction
Not applicableRecruitingImpulse Dynamics15002022-02-032026-10-23
Optimizer System With ODOCOR II CCM™ Leads
ODOCOR II CCM LEADS - Evaluate the Safety and Useability of the ODOCOR II Intra-cardiac Lead
UnknownImpulse Dynamics2002021-03-012023-08-02
Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy
OPTIMIZER Smart System - Heart Failure
Active not recruitingImpulse Dynamics6202020-01-212025-11-20
CCM in Heart Failure With Preserved Ejection Fraction
Optimizer SMART - Heart Failure, Diastolic
Not applicableCompletedImpulse Dynamics472018-05-012024-04-23
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
Optimizer Smart System with 2-leads - Heart Failure, Congestive Heart Failure
Not applicableCompletedImpulse Dynamics602017-10-232020-01-14
Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
Optimizer Smart System - Heart Failure, Congestive Heart Failure
Not applicableTerminatedImpulse Dynamics1062017-07-012021-11-23
Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure
OPTIMIZER, Optimal medical therapy - Heart Failure
Not applicableTerminatedImpulse Dynamics502014-02-012020-09-02
Effects of CCM-therapy in Patients With Heart Failure
Heart Failure
CompletedStiftung Institut fuer Herzinfarktforschung1842011-09-012016-09-09
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Optimizer System, No intervention: Optimal medical therapy - NYHA Class III Heart Failure, NYHA Class IV Heart Failure
Not applicableCompletedImpulse Dynamics1602011-01-012021-09-17
Evaluation of the Safety and Effectiveness of the OPTIMIZER System in Subjects With Heart Failure: FIX-HF-5
OPTIMIZER System - Heart Failure, Congestive
Not applicableCompletedImpulse Dynamics4282005-02-012020-08-06

Conditions studied

Heart Failure (15)  ·  Arrhythmias, Cardiac (2)  ·  Heart Failure, Diastolic (2)  ·  Atrial Fibrillation (1)  ·  Bundle-Branch Block (1)  ·  Chagas Cardiomyopathy (1)  ·  Death, Sudden, Cardiac (1)  ·  Heart Failure, Systolic (1)  ·  Tachycardia, Ventricular (1)  ·  Ventricular Dysfunction, Left (1)  ·  Ventricular Fibrillation (1)

Interventions

Angiotensin Receptor Antagonists (1)  ·  Mineralocorticoid Receptor Antagonists (1)  ·  Mutagenesis, Insertional (1)

Countries

United States (10)  ·  Germany (6)  ·  Italy (4)  ·  Czechia (2)  ·  Poland (2)  ·  Spain (2)  ·  Sweden (2)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Portugal (1)

Top investigators

Daniel Burkhoff, MD, PhD (2)  ·  Andrew Remppis, Professor (1)  ·  Anthony Hong (1)  ·  Carsten Tschoepe, Prof. (1)  ·  Dan Burkhoff, M.D, Ph.D. (1)  ·  David D. Gutterman, MD (1)  ·  Francesco Zanon, MD (1)  ·  Gerhard Hindricks, Prof. (1)  ·  Javed Butler, MD, MPH, MBA (1)  ·  Lee Ming Boo (1)  ·  Nir Uriel, MD (1)  ·  Niraj Varma, MD, PhD (1)  ·  Oussama Wazni, MD, MBA (1)  ·  Rami Kahwash, MD (1)  ·  Raul Weiss, MD (1)

Results publications

PMID 10677747, PMID 10707756, PMID 11175486, PMID 15845889, PMID 16202650, PMID 16928995, PMID 17339569, PMID 17891282, PMID 18545843, PMID 18926146, PMID 19131444, PMID 19142374, PMID 19168514, PMID 19753454, PMID 20399979, PMID 23621145, PMID 2365530, PMID 2486527, PMID 27394714, PMID 29754812, PMID 31772622, PMID 32264716, PMID 35855646, PMID 37980262, PMID 3997291, PMID 4982469, PMID 4994717, PMID 7055867, PMID 7547025, PMID 7987526, PMID 7994859, PMID 8175216, PMID 8187110, PMID 8650479, PMID 8728813, PMID 8904674